Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproate-associated pancreatitis

J J Asconapé1, J K Penry, F E Dreifuss

  • 1Department of Neurology, Bowman Gray School of Medicine, Wake Forest University, Winston Salem, North Carolina 27157-1078.

Epilepsia
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Routine antenatal ultrasound in low- and middle-income countries: first look - a cluster randomised trial.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Exogenous tannase improves feeding value of a diet containing field beans (Vicia faba) when fed to broilers.

British poultry science·2016
Same author

Preface.

Behavioural neurology·2014
Same author

Specialty choices of medical students and house officers in Karachi, Pakistan.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2011
Same author

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.

Neurology·2001
Same author

Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing.

Epilepsia·1999
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Valproate (VPA) can cause pancreatitis, particularly in young patients during the first year of treatment. Early VPA discontinuation can reverse this serious condition.

Area of Science:

  • Neurology
  • Gastroenterology
  • Pharmacology

Background:

  • Valproate (VPA) is a widely used antiepileptic drug.
  • Pancreatitis is a potential adverse effect of VPA therapy.
  • Assessing the clinical profile of VPA-associated pancreatitis is crucial for patient safety.

Observation:

  • Data was collected from physician surveys, author patient populations, and literature reviews.
  • 53 out of 366 surveyed physicians (14.5%) reported VPA-associated pancreatitis cases.
  • 39 cases were analyzed, with a mean age of 16.4 years, indicating a higher risk in younger individuals.

Findings:

  • The highest risk for pancreatitis occurred within the first year of VPA treatment (43.8% in 3 months, 68.8% in 1 year).
  • Patients on polytherapy (76%) and those with chronic encephalopathy (41%) showed increased risk.

Related Experiment Videos

  • Most cases resolved upon VPA discontinuation, though 6 were severe with 3 reported deaths. Rechallenge led to high relapse rates.

    • Implications:

    • Early recognition and discontinuation of VPA are vital for preventing severe pancreatitis.
    • Physicians should be aware of VPA-induced pancreatitis, especially in at-risk populations.
    • Monitoring for asymptomatic amylase elevation may aid in early detection.